125 SUMMER STREET, BOSTON, MA
Reports First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance
Shareholder votes
Annual Report to Security Holders
Reports Fourth Quarter and Fiscal 2025 Results; Provides Fiscal 2026 Guidance
Reports Third Quarter and Year-to-Date Fiscal 2025 Results; Updates Fiscal 2025 Guidance
Completes Sale of Whole Blood Assets to GVS, S.p.A
Changes in Board, Management or Compensation
Announces Sale of Whole Blood Assets to GVS, S.p.A
Q1
FY 2024
Q3
Q2
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report